Vanta Bioscience (BOM:540729) Retained Earnings : ₹0.00 Mil (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Vanta Bioscience Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Vanta Bioscience's retained earnings for the quarter that ended in Sep. 2024 was ₹0.00 Mil.

Vanta Bioscience's quarterly retained earnings declined from Sep. 2023 (₹0.00 Mil) to Mar. 2024 (₹-63.25 Mil) but then increased from Mar. 2024 (₹-63.25 Mil) to Sep. 2024 (₹0.00 Mil).

Vanta Bioscience's annual retained earnings declined from Mar. 2022 (₹24.83 Mil) to Mar. 2023 (₹-40.09 Mil) and declined from Mar. 2023 (₹-40.09 Mil) to Mar. 2024 (₹-63.25 Mil).

Vanta Bioscience Retained Earnings Historical Data

The historical data trend for Vanta Bioscience's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vanta Bioscience Retained Earnings Chart

Vanta Bioscience Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Retained Earnings

Get a 7-Day Free Trial

19.45

23.95

24.83

-40.09

-63.25

Vanta Bioscience Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Retained Earnings	Get a 7-Day Free Trial											-	-40.09	-	-63.25	-

Vanta Bioscience Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Vanta Bioscience (BOM:540729) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Vanta Bioscience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vanta Bioscience Ltd (BOM:540729) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 02/G/308/G, Umajay Complex, No. 3/FF/SF/1-20-248, Rasoolpura, Secunderabad, TG, IND, 500003

Website

https://www.vantabio.com

Vanta Bioscience Ltd is a full-service preclinical contract research organization. It is engaged in the provision of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation services.

Vanta Bioscience Headlines

No Headlines